Expanding dCCA to accommodate group variables with more than two categories, such as the four molecular subtypes of breast cancer (HER2-enriched, Luminal A, Luminal B, Basal-like), will significantly enhance its utility for analyzing more complex datasets. Here, ERBB2 is linked to breast carcinoma.